Gateway Investment Advisers LLC Sells 2,580 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Gateway Investment Advisers LLC decreased its position in HCA Healthcare, Inc. (NYSE:HCA) by 2.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 87,511 shares of the company’s stock after selling 2,580 shares during the period. Gateway Investment Advisers LLC’s holdings in HCA Healthcare were worth $26,266,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of HCA. MML Investors Services LLC raised its holdings in HCA Healthcare by 31.7% in the 3rd quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock worth $7,241,000 after acquiring an additional 4,285 shares during the last quarter. Meritage Group LP purchased a new position in shares of HCA Healthcare in the third quarter worth $150,548,000. Alpha DNA Investment Management LLC bought a new stake in HCA Healthcare in the 3rd quarter worth about $869,000. NRI Wealth Management LC bought a new position in HCA Healthcare during the 4th quarter valued at about $2,896,000. Finally, Czech National Bank grew its stake in shares of HCA Healthcare by 4.5% in the fourth quarter. Czech National Bank now owns 39,543 shares of the company’s stock worth $11,869,000 after acquiring an additional 1,691 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Trading Up 1.0 %

HCA stock opened at $309.26 on Friday. The company has a market capitalization of $78.34 billion, a price-to-earnings ratio of 13.89, a PEG ratio of 1.03 and a beta of 1.64. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. HCA Healthcare, Inc. has a 1-year low of $276.50 and a 1-year high of $417.14. The business has a 50 day simple moving average of $318.49 and a two-hundred day simple moving average of $353.11.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.85%. The ex-dividend date of this dividend was Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

Analysts Set New Price Targets

A number of equities research analysts have commented on HCA shares. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. Wells Fargo & Company cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their price objective for the company from $400.00 to $320.00 in a research report on Monday, November 25th. Truist Financial reduced their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. TD Cowen cut their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Finally, JPMorgan Chase & Co. reiterated a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a research note on Tuesday, December 17th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $385.27.

Insider Transactions at HCA Healthcare

In related news, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.70% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.